Fluoroethyl-L-tyrosine (18F)
 | |
| Clinical data | |
|---|---|
| Routes of administration | Intravenous |
| ATC code | |
| Identifiers | |
| |
| Synonyms | 18F-FET; O-(2-(18F)fluoroethyl)-L-tyrosine, O-(2-Fluorethyl)-L-thyrosine, L-(18F)FET[1] |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C11H14FNO3 |
| Molar mass | 227.23 g/mol |
| 3D model (JSmol) | |
| |
| |
Fluoroethyl-L-tyrosine (18F) or 18F-FET is an neuro-oncologic PET tracer.[2]
References
- ↑ CID 54255856 from PubChem
- ↑ Galldiks, N.; Stoffels, G.; Filss, C.; Rapp, M.; Blau, T.; Tscherpel, C.; Ceccon, G.; Dunkl, V.; Weinzierl, M.; Stoffel, M.; Sabel, M.; Fink, G. R.; Shah, N. J.; Langen, K.-J. (2015). "The use of dynamic O-(2-18F-fluoroethyl)-L-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma". Neuro-Oncology. doi:10.1093/neuonc/nov088.
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.